Latest Comments on ThreeBrothersHealth.com's Articles

1. somadude on Bionovo: Challenges Ahead, But Poised to Move Higher: Very good article! more »
2. ThreeBrothersHealth.com on Serada Half Price Sale: DepoMed's Stock Price Poised to Climb : Some conditions don't have testable biomarkers, thus subjective... more »
3. Robert0713 on Serada Half Price Sale: DepoMed's Stock Price Poised to Climb : It's not often, in fact never before, that I read some biopharma... more »
4. perremon on Serada Half Price Sale: DepoMed's Stock Price Poised to Climb : Time is money brother. more »
5. Chiroworks on Tylenol Ban Will Hurt Several Drug Manufacturers' Bottom Lines: I agree. As a Chiropractor I have seen the damage that... more »
6. ThreeBrothersHealth.com on Women's Health: After WHI, What's the Potential Market Size?: check out my site www.threebrothershealth.com more »
7. ThreeBrothersHealth.com on Women's Health: After WHI, What's the Potential Market Size?: menerba looks promising, probably the best drug overally, but... more »
8. arkan on Women's Health: After WHI, What's the Potential Market Size?: I think this is great,and i looked up bnvi pipeline and i think... more »
9. ThreeBrothersHealth.com on Tylenol Ban Will Hurt Several Drug Manufacturers' Bottom Lines: thanks for the edit, I changed it on my column. I doubt there... more »
10. nuknuk on Tylenol Ban Will Hurt Several Drug Manufacturers' Bottom Lines: I doubt there will be a ban... Oh, and Vicodin is spelled... more »
11. sliman on Tylenol Ban Will Hurt Several Drug Manufacturers' Bottom Lines: People have no idea how bad these medications are for their... more »
12. staples - weebs on DepoMed: Protected by Cash and Headed Higher: I took Neurontin and beside the side effects, which I do not think... more »